Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nulabeglogene autogedtemcel - LENZ Therapeutics

Next Previous
Drug Profile

Nulabeglogene autogedtemcel - LENZ Therapeutics

Alternative Names: Autologous CD34+ Hematopoietic Stem Cells - LENZ Therapeutics; GPH-101 - Graphite Bio; nula-cel

Latest Information Update: 26 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Stanford University
  • Developer Kamau Therapeutics
  • Class Antianaemics; Gene therapies; Haematopoietic stem cells therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Sickle cell anaemia
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Sickle cell anaemia

Most Recent Events

  • 21 Mar 2024 LENZ Therapeutics has merged with Graphite Bio to form LENZ Therapeutics
  • 31 Jan 2024 Kamau Therapeutics reinitiates enrollment in the phase-I/II CEDAR trial in Sickle cell anaemia (In adolescents, In adults) in USA (IV) (NCT04819841)
  • 08 Dec 2023 Kamau Therapeutics enters option to acquire agreement with Graphite Bio

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top